Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26F4F3Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,758
Award facts
- Contract value 100% obligated
- $19,758.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $19,758.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tezspire 210 mg/1.91 ml pen injectors. The contract, awarded on January 21, 2026, with an ultimate completion date of February 11, 2026, represents a non-set-aside competitive award executed through the company's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is the vendor's corporate office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the AmerisourceBergen brand), is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
This delivery order falls under AmerisourceBergen's comprehensive $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and active through December 2026. The IDC functions as a global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide. Tezspire is a biologic medication used for severe asthma treatment, and this order reflects the company's ongoing role in supplying specialty medications and healthcare commodities to support the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F4F3Q?
SPE2DR26F4F3Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F4F3Q worth?
The government has obligated $19,758 on SPE2DR26F4F3Q.
Is contract SPE2DR26F4F3Q an order under another contract?
Yes. SPE2DR26F4F3Q is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4F3Q competed?
The extent of competition for SPE2DR26F4F3Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award